Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Holdenrieder

Showing results (1-10 of 290) with videos related to

Pageof 29
Sort By:
Advances in Experimental Medicine and Biology|October 19, 2016
Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer PatientsStefan Holdenrieder
Personalized Medicine|May 16, 2018
Circulating nucleosomes: a new addition to the personalized medicine toolkitStefan Holdenrieder
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 20, 2016
Biomarkers along the continuum of care in lung cancerStefan Holdenrieder
Diagnostics (Basel, Switzerland)|February 9, 2016
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesChristin Pilzweger, Stefan Holdenrieder
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
New challenges for laboratory diagnostics in non-small cell lung cancerStefan Holdenrieder, Petra Stieber
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 6, 2023
Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 updateInga Trulson, Stefan Holdenrieder
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
Circulating apoptotic markers in the management of non-small cell lung cancerStefan Holdenrieder, Petra Stieber
Journal of Molecular Medicine (Berlin, Germany)|October 26, 2017
Circular RNA maps paving the road to biomarker development?Agnes Görlach, Stefan Holdenrieder
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
Lung cancer biomarkers - Where we are and what we needPetra Stieber, Stefan Holdenrieder
Critical Reviews in Clinical Laboratory Sciences|December 25, 2008
Clinical use of circulating nucleosomesStefan Holdenrieder, Petra Stieber
Pageof 29

Showing results (1-10 of 290) with videos related to

Sort By:
Pageof 29
Advances in Experimental Medicine and Biology|October 19, 2016
Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer PatientsStefan Holdenrieder
Personalized Medicine|May 16, 2018
Circulating nucleosomes: a new addition to the personalized medicine toolkitStefan Holdenrieder
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 20, 2016
Biomarkers along the continuum of care in lung cancerStefan Holdenrieder
Diagnostics (Basel, Switzerland)|February 9, 2016
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesChristin Pilzweger, Stefan Holdenrieder
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
New challenges for laboratory diagnostics in non-small cell lung cancerStefan Holdenrieder, Petra Stieber
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 6, 2023
Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 updateInga Trulson, Stefan Holdenrieder
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
Circulating apoptotic markers in the management of non-small cell lung cancerStefan Holdenrieder, Petra Stieber
Journal of Molecular Medicine (Berlin, Germany)|October 26, 2017
Circular RNA maps paving the road to biomarker development?Agnes Görlach, Stefan Holdenrieder
Cancer Biomarkers : Section a of Disease Markers|July 28, 2010
Lung cancer biomarkers - Where we are and what we needPetra Stieber, Stefan Holdenrieder
Critical Reviews in Clinical Laboratory Sciences|December 25, 2008
Clinical use of circulating nucleosomesStefan Holdenrieder, Petra Stieber
Pageof 29